SILO Pharma Inc’s recent filing unveils that its CEO and President Weisblum Eric acquired Company’s shares for reported $2097.0 on Dec 13 ’24. In the deal valued at $0.84 per share,2,500 shares were bought. As a result of this transaction, Weisblum Eric now holds 187,932 shares worth roughly $0.2 million.
Then, Weisblum Eric bought 2,500 shares, generating $2,375 in total proceeds. Upon buying the shares at $0.95, the CEO and President now owns 182,932 shares.
Before that, Weisblum Eric bought 2,500 shares. SILO Pharma Inc shares valued at $2,250 were divested by the CEO and President at a price of $0.90 per share. As a result of the transaction, Weisblum Eric now holds 185,432 shares, worth roughly $0.2 million.
Price Performance Review of SILO
On Monday, SILO Pharma Inc [NASDAQ:SILO] saw its stock jump 31.30% to $1.07. Over the last five days, the stock has gained 44.24%. SILO Pharma Inc shares have risen nearly 20.22% since the year began. Nevertheless, the stocks have fallen -40.56% over the past one year. While a 52-week high of $4.50 was reached on 01/08/25, a 52-week low of $0.71 was recorded on 04/30/25. SMA at 50 days reached $1.1199, while 200 days put it at $1.2390.
Levels Of Support And Resistance For SILO Stock
The 24-hour chart illustrates a support level at 0.8960, which if violated will result in even more drops to 0.7220. On the upside, there is a resistance level at 1.1670. A further resistance level may holdings at 1.2640. The Relative Strength Index (RSI) on the 14-day chart is 56.68, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.0108, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 25.00%. Stochastics %K at 39.57% indicates the stock is a holding.
